Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-07-23
1995-08-08
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
552511, A61K 3156, C07J 700
Patent
active
054399017
ABSTRACT:
The present invention relates to the compound cyproterone thiopivalate (CTP) and compositions comprising CTP. The present invention further relates to methods of treating acne and/or sebaceous gland activity comprising topical application of CTP. The present invention additionally relates to methods of regulating hair growth comprising application of compositions comprising CTP.
REFERENCES:
patent: 3234093 (1966-02-01), Wierchert et al.
patent: 4014909 (1977-03-01), Torossian et al.
patent: 4098803 (1978-07-01), Torossian et al.
patent: 4098804 (1978-07-01), Torossian et al.
patent: 4177268 (1979-12-01), Torossian et al.
patent: 4269778 (1981-05-01), Torossian et al.
patent: 4361559 (1982-11-01), Varma
patent: 4861765 (1989-08-01), Mituskuchi et al.
patent: 4877781 (1989-10-01), LaHaye et al.
patent: 5021408 (1991-06-01), Aubard et al.
Bettendorf, G., "Effect of Cyproterone in Female Virilizing Syndromes", Proceedings of 3rd Meeting of International Study Group on Steroid Hormones, vol. 3, pp. 267-276 (1968).
Bodor, N. "The Application of Soft Drug Approaches to the Design of Safer Corticosteroids", Topical Corticosteroid Therapy: A Novel Approach to Safer Drugs, pp. 13-25 (1988).
Bodor, N. "Soft Drugs: Principles and Methods for the Design of Safe Drugs", Medicinal Research Reviews, vol. 4, No. 4, pp. 449-469 (1984).
Bodor, N. and K. B. Sloan, "Soft Drugs V: Thiazolidine-Type Derivatives of Progesterone and Testosterone", Journal of Pharmaceutical Sciences, vol. 71, No. 5, pp. 514-520 (May 1982).
Burton, J. L., U. Laschet and S. Shuster, "Reduction of Sebum Excretion in Man by the Antiandrogen, Cyproterone Acetate", British Journal of Dermatology, vol. 89, pp. 487-490 (1973).
Chanoine, F. and J. L. Junien, "Comparative Pharmacokinetic Studies of Tixocortol Pivalate and Cortisol in the Rat", J. Steroid Biochem, vol. 21, No. 4, pp. 453-459 (1984).
Cunliffe, W. J., S. SHuster and A. J. Cassels Smith, "The Effect of Topical Cyproterone Acetate on Sebum Secretion in Patients With Acne", Br. J. Derm., vol. 81, No. 3, pp. 200-201 (1969).
Dawber, R. P. R., T. Sonnex and I. Ralfs, "Oral Anti-androgen Treatment of Common Baldness in Women", B. J. Derm., Suppl. 22, vol. 107, p. 20 (1982).
Devlin, R. G., A. Dean, K. Kripalani, J. R. Taylor and A. A. Sugerman, "Percutaneous Absorption and Adrenal Suppressive Potency of Tipredane, A New Topical Corticosteroid", J. Toxicol . . .--Cut, & Ocular Toxicol., vol. 5, No. 1, pp. 35-43 (1986).
Huber, J., R. Zeillinger, J. Spona, J. Schmidt, U. Tauber and W. Kuhnz, "Parenteral and Peroral Cyproterone Acetate (CPA) in Severe Hirsutism", Proceedings of World Congress of Dermatology, Berlin, May 24-29, 1987.
Lan, S. J., L. M. Scanlan, S. H. Weinstein, R. K. Varma, B. M. Warrack, S. E. Unger, M. A. Porubcan and B. H. Migdalof, "Biotransformation of Tipredane, A Novel Topical Steroid, In Mouse, Rat, and Human Liver Homogenates", Drug Metabolism and Disposition, vol. 17, No. 5, pp. 532-541, 1988.
Lan, S. J., L. M. Scanlan, J. Mitroka, S. H. Weinstein, B. N. Lutsky, C. A. Free, R. J. Wonjar, R. C. Millonig and B. H. Migdalof, "Rapid Metabolic Inactivation of Tipredane, A Structurally Novel Topical Steroid", Journal of Steroid Biochemistry, vol. 31, No. 5, pp. 825-834 (1988).
Larochelle, P., P. Du Souich, E. Bolte, J. Lelorier and R. Goyer, "Tixocortol Pivalate, a Corticosteroid With No Systemic Glucocorticoid Effect After Oral, Intrarectal, and Intranasal Application", Clin. Pharmacol. Ther., vol. 33, No. 3, pp. 343-350 (Mar. 1983).
Lutsky, B. N., R. C. Millonig, R. J. Wojnar, C. A. Free, R. G. Devlin, R. K. Varma and D. S. Karanewsky, "Androstene-17-thioketals", Arzneim.-Forsch./Drug Res., vol. 36(II), No. 12, pp. 1787-1795 (1986).
Lyons, F. and S. Shuster, "Indirect Evidence That The Action of Cyproterone Acetate On The Skin is Due To A Metabolite", Clinical Endocrinology, vol. 19, pp. 53-55 (1983).
Matias, J. and N. Orentreich, "The Effect of Androgens, Antiandrogens, and Vasodilating Agents on Hair Loss in the Androchronogenetic Alopecia (AGA)--Mouse Model", Proceedings of World Congress of Dermatology, Berlin, May 24-29, 1987.
Neumann, F., R. von Berswordt-Wallrabe, W. Elger, H. Steinbeck, J. D. Hahn and M. Kramer, "Aspects of Androgen-Dependent Events as Studied by Antiandrogens", Recent Progress in Hormone Research, vol. 26, pp. 337-410 (1970).
Pye, R. J., J. L. Burton and J. I. Harris, "Effect of 1% Cyproterone Acetate in Cetomacrogol Cream BPC (Formula A) on Sebum Excretion Rate in Patients With Acne", British Journal of Dermatology, vol. 95, No. 4, pp. 427-428 (Oct. 1976).
Vermorken, A. J. M., "Reversal of Androgenic Alopecia by Minoxidil: Lack of Effect of Simultaneously Administered Intermediate Doses of Cyproterone Acetate", Acta Dermatovener, vol. 63, pp. 268-269 1982.
Voigt, W. and S. L. Hsia, "Further Studies on Testosterone 5.sub..alpha. -Reductase of Human Skin", The Journal of Biological Chemistry, vol. 218, No. 12, pp. 4280-4285 (Jun. 1973).
Wendt, H., S. H. Hasan, I. Heinze and U. Tauber, "Systemic Effects of Local Antiandrogen Therapy", Arch Dermatol. Res., vol. 273, p. 171 (1982).
Wiechert, Neumann, "Cyproterone", The Merck Index, 11th Edition, p. 435 1989.
Wojnar, R. J., R. K. Varma, C. A. Free, R. C. Millonig, D. Karanewsky and B. N. Lutsky, "Androstene-17-thioketals", Arzneim.-Forsch./Drug. Res., vol. 36(II), No. 12, pp. 1782-1787 (1986).
Schwen Richard J.
Sine Mark R.
Warren Raphael
Cook Rebecca
Corstanje Brahm J.
Rasser Jacobus C.
Richter Johann
Suter David L.
LandOfFree
Cyproterone thiopivalate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyproterone thiopivalate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyproterone thiopivalate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-971282